PaySign, Inc. (PAYS) key performance indicators and operating metrics (15 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 10.59M | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Per Share (Fully Diluted) | 0.17 USD_per_share | FY2026-Q1 |
| Pharma Industry Revenue | 15.68M | FY2026-Q1 |
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization Margin | 37.80 percent | FY2026-Q1 |
| Plasma Donor Compensation Revenue | 11.75M | FY2026-Q1 |
| Average Monthly Revenue Per Plasma Center | 6.67K | FY2026-Q1 |
| Other Revenue | 610.36K | FY2026-Q1 |
| Plasma Donation Centers | 573.00 | FY2026-Q1 |
| Gross Dollar Load Volume Growth | 26.40 percent | FY2026-Q1 |
| Gross Spend Volume Growth | 26.70 percent | FY2026-Q1 |
| Active Patient Affordability Programs | 135.00 | FY2026-Q1 |
| Plasma Revenue | 12.6M | FY2025-Q4 |
| Average Quarterly Revenue Per Pharma Patient Affordability Program | 75.43K | FY2025-Q3 |
| Card Programs | 630.00 | FY2025-Q1 |
Back to PAYS overview · PAYS earnings · PAYS holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.